Market Cap 15.19M
Revenue (ttm) 14.60M
Net Income (ttm) -10.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -70.89%
Debt to Equity Ratio 0.42
Volume 87,500
Avg Vol 12,998
Day's Range N/A - N/A
Shares Out 9.61M
Stochastic %K 93%
Beta 0.91
Analysts Strong Sell
Price Target $4.80

Company Profile

LiqTech International, Inc., a clean technology company, manufactures and markets specialized filtration products and systems in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. It operates through three segments: Water, Ceramics, and Plastics. The company also manufactures and sells silicon carbide ceramic filtration technologies for liquid and gas purification; and diesel particulate filters for exhaust emission control solutions to the verified retrofit and the original eq...

Industry: Pollution & Treatment Controls
Sector: Industrials
Phone: 45 31 31 59 41
Website: liqtech.com
Address:
Industriparken 22C, Ballerup, Denmark
RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
iamEdom
iamEdom Jun. 25 at 3:30 PM
$LIQT 😁🚀🚀🚀🚀🚀
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 25 at 1:03 PM
$LIQT OMG! A sale!
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 16 at 11:05 AM
WATCHLIST JUN 16 2025. $AIOT Powerfleet Expands Deployment Of Advanced AI Video Safety Solution With EverDriven Technologies $LLY Eli Lilly Announces That The Highest Approved Doses Of Zepbound (Tirzepatide)—12.5 mg And 15 mg—Will Soon Be Available In Single-dose Vials For $499 Per Month Through LillyDirect's Self Pay Pharmacy Solutions And The Zepbound Self Pay Journey Program $LIQT Ascendiant Capital Maintains Buy on LiqTech International, Raises Price Target to $3.6 $CNTB Connect Biopharma Presents Clinical Data Supporting Rademikibart, Anti-Interleukin-4-Receptor Alpha Antibody At EAACI 2025 Annual Congress $TTE TotalEnergies Partners With Petronas In Multiple Blocks Offshore Malaysia And One Block Offshore Indonesia
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 11:00 AM
Ascendiant Capital has updated their rating for LiqTech International ( $LIQT ) to Buy with a price target of 3.6.
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 3 at 6:32 PM
$LIQT been racking up the big volume days lately. News around the corner Fei?
1 · Reply
RollingDollars
RollingDollars Jun. 3 at 2:48 PM
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 14 at 12:35 PM
$LIQT circling back to the margins issue — Fei better not be selling any more PureFlow systems at cost. We’re here to make money. I get that the first one was a reference install to help future sales, but that excuse has a shelf life. Starting now, every unit should carry real margin.
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 14 at 12:17 PM
$LIQT you've pulled me back in my queen. They hit the high end of their Q1 revenue guide at $4.6M (+36% QoQ, +9% YoY). Margins still a drag — gross margin came in at 2.7%, but that's a step up from last quarter’s negative margin. Q2 guidance of $4.8M–$5.2M gets them within striking distance of the $5.5M–$6.0M breakeven target. You get me for another quarter, Fei.
0 · Reply
Latest News on LIQT
LiqTech Obtains NSF Certification for Pool System Solution in U.S.

Aug 13, 2024, 9:00 AM EDT - 11 months ago

LiqTech Obtains NSF Certification for Pool System Solution in U.S.


RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
RollingDollars
RollingDollars Jun. 27 at 7:33 PM
0 · Reply
iamEdom
iamEdom Jun. 25 at 3:30 PM
$LIQT 😁🚀🚀🚀🚀🚀
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 25 at 1:03 PM
$LIQT OMG! A sale!
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 16 at 11:05 AM
WATCHLIST JUN 16 2025. $AIOT Powerfleet Expands Deployment Of Advanced AI Video Safety Solution With EverDriven Technologies $LLY Eli Lilly Announces That The Highest Approved Doses Of Zepbound (Tirzepatide)—12.5 mg And 15 mg—Will Soon Be Available In Single-dose Vials For $499 Per Month Through LillyDirect's Self Pay Pharmacy Solutions And The Zepbound Self Pay Journey Program $LIQT Ascendiant Capital Maintains Buy on LiqTech International, Raises Price Target to $3.6 $CNTB Connect Biopharma Presents Clinical Data Supporting Rademikibart, Anti-Interleukin-4-Receptor Alpha Antibody At EAACI 2025 Annual Congress $TTE TotalEnergies Partners With Petronas In Multiple Blocks Offshore Malaysia And One Block Offshore Indonesia
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 11:00 AM
Ascendiant Capital has updated their rating for LiqTech International ( $LIQT ) to Buy with a price target of 3.6.
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 3 at 6:32 PM
$LIQT been racking up the big volume days lately. News around the corner Fei?
1 · Reply
RollingDollars
RollingDollars Jun. 3 at 2:48 PM
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 14 at 12:35 PM
$LIQT circling back to the margins issue — Fei better not be selling any more PureFlow systems at cost. We’re here to make money. I get that the first one was a reference install to help future sales, but that excuse has a shelf life. Starting now, every unit should carry real margin.
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 14 at 12:17 PM
$LIQT you've pulled me back in my queen. They hit the high end of their Q1 revenue guide at $4.6M (+36% QoQ, +9% YoY). Margins still a drag — gross margin came in at 2.7%, but that's a step up from last quarter’s negative margin. Q2 guidance of $4.8M–$5.2M gets them within striking distance of the $5.5M–$6.0M breakeven target. You get me for another quarter, Fei.
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 14 at 12:07 PM
$LIQT Q1 2025 shows sequential revenue growth of 36% to $4.6M, with China JV already securing marine scrubber orders. Guidance suggests continued momentum (Q2 rev $4.8-5.2M). Bullish on expanding oil/gas and lithium brine pilots, but that 2.7% gross margin stings. Cash position solid at $10.4M. Conference call today - let's see if the street buys the turnaround narrative. https://www.prnewswire.com/news-releases/liqtech-international-announces-first-quarter-2025-financial-results-302454416.html
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen May. 7 at 1:23 AM
$LIQT I'm losing faith Fei
0 · Reply
mag_x
mag_x Apr. 21 at 11:14 PM
$LIQT Feiiiii
0 · Reply
Mustang8
Mustang8 Apr. 9 at 6:08 PM
$LIQT looks good
0 · Reply
JarvisFlow
JarvisFlow Apr. 7 at 11:00 AM
Ascendiant Capital updates rating for LiqTech Intl ( $LIQT ) to Buy, target set at 3.2 → 3.4.
0 · Reply
erevnon
erevnon Apr. 7 at 10:50 AM
Ascendiant Capital reiterates LiqTech Intl $LIQT at Buy and raises the price target from $3.2 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
mikesterz7
mikesterz7 Mar. 28 at 12:20 PM
$LIQT LiqTech International reported Q4 2024 financial results with revenue of $3.4 million, up 37% sequentially but down 13% year-over-year. Full-year 2024 revenue decreased 19% to $14.6 million, with a net loss of $(10.3) million compared to $(8.6) million in 2023. The company implemented cost reduction strategies including a 10% headcount reduction, 10% salary cuts for senior management, and 50% reduction in board compensation. The break-even target is now set at $5.5-6.0 million quarterly revenue. Key highlights include a record commercial order for PureFlow™ mobile units, three operational pilot units for various markets including lithium harvesting, and new swimming pool system deliveries. Q1 2025 guidance projects revenue between $4.3-4.7 million, representing 26-38% sequential growth.
0 · Reply
DARKP00L
DARKP00L Mar. 28 at 12:13 PM
$LIQT 08:12 on Mar. 28 2025 LiqTech International Implemented Cost Reduction Strategy That Includes 10% Reduction In Headcount, 10% Reduction In Base Salaries For Senior Management, 50% Reduction In Cash Compensation For The Board Of Directors In 2025 #tradeideas
0 · Reply
DARKP00L
DARKP00L Mar. 28 at 12:10 PM
$LIQT 08:10 on Mar. 28 2025 LiqTech International Sees Q1 2025 Revenue Between $4.3M-$4.7M Vs. $4.90M Estimate #tradeideas
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Mar. 28 at 12:10 PM
$LIQT Q4 – My Take Hit the low end of the revenue guide but stayed within range (3.4 million) Q1 guide looks strong with 26–38% sequential growth expected, driven by Razorback (4.3-4.7 million) Encouraging step forward — but need to see a couple of quarters of solid execution before calling it a true turnaround.
1 · Reply
DonCorleone77
DonCorleone77 Mar. 28 at 12:04 PM
$LIQT LiqTech sees Q1 revenue $4.3M-$4.7M, one estimate $4.5M
0 · Reply
DonCorleone77
DonCorleone77 Mar. 28 at 12:03 PM
$LIQT LiqTech reports Q4 EPS (39c) vs. (56c) last year Reports Q4 revenue $3.41M vs. $3.93M last year. "The 37% sequential revenue growth experienced during Q4 2024 came within the expectations we provided back in November 2024 as we expanded the number of pilot systems in operation and saw improvement in our swimming pool business. Since that time, we received a record commercial order for our PureFlow Mobile Units to the oil and gas industry which will be completed and contribute to further sequential revenue growth expected during Q1 2025. All told, our expectation for Q1 2025 shows sequential revenue growth of 26% to 38% as recent orders received during the past few months are shipped," commented Fei Chen, CEO of LiqTech. "Further, we have implemented a cost reduction strategy aimed at lowering our break-even target, measured on an adjusted EBITDA basis, to a quarterly revenue of approximately $5.5 to $6.0 million. These initiatives include a reduction in headcount, reduction in basic salary for senior management, and a reduction in cash compensation by the board of directors. With revenue growth expected and cost savings implemented, we are on the pathway to profitability, a key management objective for 2025."
0 · Reply